Director/PDMR Shareholding

AI SummaryClose X

Roquefort Therapeutics plc announced that Interim Managing Director Dr. Darrin Disley purchased 5,000,000 ordinary shares at an average price of 1.70 pence per share, totaling £85,000. This transaction increases his total shareholding to 7,024,196 ordinary shares, representing 4.46% of the company's issued capital. The purchase occurred on November 21, 2025, on the London Stock Exchange.

Disclaimer*

UK 100

Latest directors dealings